An increasing number of chILD patients are reaching adulthood. However, studies show that there are no standards in place to optimize the transition to adult care, as well as diagnoses and treatments.
Dr. Cheng-Yu Wu, DZL scientist at Justus Liebig University Giessen, receives €116,600 for his COPD research. He investigates how oxidative stress and inflammation contribute to the disease in order to develop new therapeutic approaches.
Dr. Alberto Hidalgo, a fellow of the DZL Academy at Helmholtz Center Munich, has been awarded approximately €100,000 through the GOBio Initial program, funded by the German Federal Ministry of Education and Research (BMBF).
A research team led by Dr. Malte Lücken, DZL scientist at Helmholtz Munich (DZL site CPC-M), has published a guide for creating single-cell atlases in the renowned journal Nature Methods.
The COVIDOM+ study, led by Kiel University Medicine with the involvement of UKSH and CAU, has received €4.9 million in funding to research the long-term effects of COVID-19. The aim is to develop more precise...
How do very preterm babies breathe? What respiratory mechanisms help them manage the complex transition from intrauterine life to life outside the womb? DZL scientists in Munich explored this intriguing question.
Scientists at the European Molecular Biology Laboratory (EMBL) have identified dextromethorphan, an FDA-approved over-the-counter cough suppressant, as a potential treatment for pulmonary fibrosis. Initial tests indicate that this compound may inhibit scarring in the lungs.
At the Young Investigator Meeting of the DZL Disease Area DPLD, researchers from all five DZL sites gathered in Hanover on December 2–3, 2024. The event focused on scientific exchange, networking, and the presentation of...
An interdisciplinary team of DZL researchers from MHH has gained new insights into the role of so-called "aberrant basaloid cells" in idiopathic pulmonary fibrosis (IPF). The research findings help to understand how pathological changes in...
Early-career scientists from DGP and the DZL Academy convened to discuss the latest insights into lung diseases and innovative research methodologies. While inspiring keynotes set the scene, the spotlight was firmly on the early-career scientists.
The DZG Science & Career Day 2024 in Potsdam provided early-career researchers with valuable insights into translational research, along with numerous opportunities for interdisciplinary exchange and networking.
A new AI-driven imaging platform enables precise drug delivery to targeted areas of the lung, enhancing treatment for lung diseases. It also offers valuable insights into lung biology, improving the effectiveness of inhalation therapies.
